狂犬病疫苗市场报告：趋势、预测和竞争分析（至 2031 年）

由于医院、居家医疗和专科诊所市场存在机会，全球狂犬病疫苗市场的未来前景光明。预计到 2031 年全球狂犬病疫苗市场规模将达到 13 亿美元，2025 年至 2031 年的复合年增长率为 4.4%。市场的主要驱动力是人们对狂犬病风险的认识不断提高，以及加强对狐狸和浣熊等野生动物狂犬病的控制力度。

• 根据产品类型，Lucintel 预测 Vero 细胞将是最有望在预测期内增长的细胞，因为它具有可行性、安全性和高免疫抗原性等诸多优点，并可用于暴露前和暴露后预防。
• 根据最终用途，由于医院狂犬病疫苗接种处方数量的增加，预计市场将在预测期内见证最高增长。
• 按地区划分，北美凭藉其强大的医疗保健基础设施和不断增长的製药公司数量将继续成为最大的地区。

狂犬病疫苗市场的策略性成长机会

狂犬病疫苗市场在关键应用领域提供了多种策略成长机会。这些包括疫苗技术的进步、认识的提高和公共卫生倡议的加强。

• 人类疫苗接种计划：人类狂犬病疫苗接种计划的发展，特别是在高风险地区，代表着巨大的成长机会。改善服务取得途径和进行有针对性的宣传活动将有助于控制和预防疾病。
• 动物疫苗接种工作：对动物进行疫苗接种以防止狂犬病传播的需求日益增加。透过专注于动物接种疫苗，我们可以控制狂​​犬病的发生并减少人类的感染。
• 联合疫苗的开发：提供可以预防多种疾病的联合疫苗也是一个成长机会。这样的疫苗接种计画会更简单，病人也更容易遵守。
• 创新的给药方法：另一种可能性是研究创新的疫苗给药方法，例如微针贴片或口服疫苗。这些可以帮助提高疫苗接受度并使接种疫苗更加方便。
• 扩大市场进入：改善分销和物流将增加新兴市场的准入，为市场扩张提供机会。这些努力将确保先前稀缺的疫苗能够在医疗资源匮乏的地区更广泛地普及，从而促进更大的市场渗透。

这些成长机会正在推动创新、扩大获取途径和改善疾病控制，从而塑造狂犬病疫苗市场。需要应对这些挑战，才能有效解决全球狂犬病问题并加强公共卫生干预。

狂犬病疫苗市场驱动因素与挑战

狂犬病疫苗市场受到各种市场驱动因素和挑战的影响，包括技术进步、经济因素和监管考量。了解这些因素对于市场发展至关重要。

推动狂犬病疫苗市场发展的因素有：

• 技术进步：疫苗技术市场的成长受到创新重组和组合疫苗的推动。这些变化提高了产品的安全性和有效性，并改善了疾病控制。
• 提高意识和教育：人们对狂犬病及其疫苗接种的认识不断提高，导致对疫苗的需求增加。因此，需要开展健康宣传活动和教育活动来提高疫苗接种覆盖率。
• 政府倡议：政府的支持政策和狂犬病疫苗接种计划的资金推动了市场扩张。政府在扩大疫苗接种覆盖率和控制疫情方面的作用怎么强调也不为过。
• 扩大疫苗接种管道：改进的分发系统和物流使服务不足的社区能够获得疫苗，并接种比以往更多的疫苗。改进的低温运输管理加上有针对性的计划正在促进疫苗的广泛普及。
• 研究与开发：疫苗技术的创新仍在继续，包括新的输送系统。如果没有这些研究和开发，我们就没有机会开发更有效、更方便的疫苗接种方法。

狂犬病疫苗市场面临的挑战是：

• 监管障碍：由于监管要求复杂，在产品开发过程中以及尝试获得疫苗核准时遵守各种国际标准可能会很困难。疫苗的核准过程很困难，因为必须满足国际上的多项标准，这使得产品开发和市场开发变得复杂。
• 高成本：开发和生产先进疫苗的成本非常高，这会影响定价和可负担性，特别是在非洲等狂犬病高度流行的资源贫乏的国家。生产此类疫苗需要大量资金，成本昂贵。
• 疫苗犹豫：提高疫苗接种率取决于解决疫苗犹豫和错误讯息。消除接受疫苗的障碍需要公众教育和参与。

这些市场驱动因素和挑战影响了创新、取得和公共卫生计划，从而对狂犬病疫苗市场产生了重大影响。解决这些因素将改善狂犬病控制并提高疫苗接种覆盖率。

目录

第一章执行摘要

第 2 章全球狂犬病疫苗市场：市场动态

• 简介、背景和分类
• 供应链
• 产业驱动因素与挑战

第 3 章 市场趋势与预测分析（2019-2031）

• 宏观经济趋势（2019-2024）与预测（2025-2031）
• 全球狂犬病疫苗市场趋势（2019-2024 年）及预测（2025-2031 年）
• 全球狂犬病疫苗市场（依产品类型）
  • BHK（幼仓鼠肾）
  • 狂犬病精製鸡胚细胞疫苗
  • 狂犬病 Vero 细胞疫苗
  • 其他的
• 全球狂犬病疫苗市场（依疫苗类型划分）
  • 暴露前疫苗接种（PEV）
  • 暴露后预防（PEP）
• 全球狂犬病疫苗市场（按应用）
  • 动物
  • 人类
• 全球狂犬病疫苗市场（依最终用途划分）
  • 医院
  • 居家医疗
  • 专科门诊
  • 其他的

第 4 章区域市场趋势与预测分析（2019-2031 年）

• 全球狂犬病疫苗市场（按区域）
• 北美狂犬病疫苗市场
• 欧洲狂犬病疫苗市场
• 亚太地区狂犬病疫苗市场
• 世界其他地区狂犬病疫苗市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球狂犬病疫苗市场按产品类型分類的成长机会
  • 全球狂犬病疫苗市场成长机会（依疫苗类型划分）
  • 全球狂犬病疫苗市场成长机会（按应用）
  • 全球狂犬病疫苗市场成长机会（依最终用途划分）
  • 全球狂犬病疫苗市场各区域成长机会
• 全球狂犬病疫苗市场的新趋势
• 战略分析
  • 新产品开发
  • 全球狂犬病疫苗市场产能扩张
  • 全球狂犬病疫苗市场的企业合併
  • 认证和许可

第七章主要企业简介

• Serum Institute of India
• Novartis
• Cadila Pharmaceuticals
• Merck
• Sanofi
• ADS Diagnostic
• GSK

The future of the global rabies vaccine market looks promising with opportunities in the hospital, home care, and specialty clinic markets. The global rabies vaccine market is expected to reach an estimated $1.3 billion by 2031 with a CAGR of 4.4% from 2025 to 2031. The major drivers for this market are the rising awareness of the risks of rabies and growing efforts to control rabies in wildlife populations, such as foxes and raccoons.

• Lucintel forecasts that, within the product type category, vero cell is expected to witness the highest growth over the forecast period due to its numerous benefits, such as its feasibility, safety, and high immunogenicity, and its use for pre-and post-exposure prophylaxis.
• Within the end-use category, the hospital is expected to witness the highest growth over the forecast period due to the increasing number of rabies vaccination prescriptions issued within these facilities.
• In terms of regions, North America will remain the largest region due to its robust healthcare infrastructure and the growing number of pharmaceutical companies in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Rabies Vaccine Market

Numerous technological advancements, changing healthcare needs, and an increasing global focus on disease prevention are driving the current trends in the rabies vaccine market.

• Enhanced Vaccine Technologies: These include recombinant and DNA vaccines that have improved their effectiveness and safety profiles for rabies vaccination. They offer more efficacious and less mild alternatives to the existing rabies vaccines.
• Combination Vaccines: More people today prefer combination vaccines that protect against multiple diseases, including rabies. This simplifies vaccination schedules and promotes compliance among patients.
• Expanded Access and Distribution: Currently, there is a growing focus on expanding access to low-cost rabies vaccines in low-resource settings. Better distribution networks and public health awareness campaigns are leading to higher immunization coverage rates, thus helping to control these diseases.
• Increased Focus on Animal Vaccination: In high rabies incidence areas, animal vaccination is now more important than ever before. Failure to vaccinate animals implies that humans can be affected as a consequence of an outbreak of this disease.
• Novel Delivery Methods: Ongoing studies are exploring novel methods of administering vaccines, such as microneedle patches and oral vaccines, to make vaccination more effective, especially for humans and animals.

These trends improve vaccine technology and expand access while enhancing other disease prevention strategies, thereby reshaping the rabies vaccine market, which contributes significantly to better overall worldwide control measures against rabies.

Recent Developments in the Rabies Vaccine Market

The rabies vaccine market is experiencing considerable progress as a result of technological innovation, regulatory amendments, and increased concern for disease prevention. These developments are shaping the future of rabies vaccination.

• Recombinant Vaccines: The introduction of recombinant rabies vaccines has made them safer and more effective. They involve genetic engineering, leading to newer, better immunizations with fewer side effects.
• Expanded Vaccination Campaigns: Global efforts to expand rabies vaccination campaigns are leading to greater coverage in high-risk areas. These interventions encompass human and animal vaccination schemes designed to contain outbreaks.
• Combination Vaccines: The development of combination vaccines that prevent multiple diseases is gaining momentum. Such vaccines make it easier to immunize many people at once and thus contribute positively to public health outcomes.
• Improved Distribution Networks: Advances in distribution and logistics have improved accessibility to rabies vaccines in remote and underserved areas. This includes better cold chain management and targeted vaccination programs.
• Innovative Research: Continued research on alternative vaccine technologies, such as oral vaccines and microneedle vaccinations, is advancing the field. These innovations aim to enhance vaccine delivery methods and improve patient compliance, among other goals.

By enhancing vaccine safety, increasing availability, and driving innovation, these developments significantly impact the rabies vaccine market. They are important in improving worldwide efforts to control this disease by preventing its spread through various channels.

Strategic Growth Opportunities for Rabies Vaccine Market

The rabies vaccine market offers several strategic growth opportunities in major applications. These include technological advancements in vaccines, improved awareness, and increased public health initiatives.

• Human Vaccination Programs: Developing human rabies vaccination programs, particularly in high-risk regions, represents a huge opportunity for growth. The control and prevention of disease can be facilitated through better access to services and focused campaigns.
• Animal Vaccination Initiatives: There is an increasing need to vaccinate animals to prevent the spread of rabies. Concentrating more on animal vaccinations will help control outbreaks and decrease human cases.
• Combination Vaccine Development: Offering combination vaccines that can prevent multiple illnesses is another area of opportunity for growth. Immunization schedules for these vaccines will be easier, making it easier for patients to comply with them.
• Innovative Delivery Methods: Another possibility is research into innovative vaccine delivery methods, such as microneedle patches and oral vaccines, which have growth potential. They can help enhance vaccine acceptance rates and make the doses more convenient.
• Expanded Market Access: Improvement in distribution and logistics, leading to better accessibility in emerging markets, presents expansion opportunities. Such efforts would result in wider availability of previously scarce vaccines across underserved sectors, thereby driving further market penetration.

These growth opportunities are shaping the rabies vaccine market by fostering innovation while also expanding access and improving disease control measures. They must be addressed if global rabies issues are to be dealt with effectively, thus enhancing public health interventions.

Rabies Vaccine Market Driver and Challenges

The rabies vaccine market is influenced by various drivers and challenges, including technological advancements, economic factors, and regulatory considerations. Understanding these elements is crucial for market development.

The factors responsible for driving the rabies vaccine market include:

• Technological Advancements: Market growth in vaccine technology can be attributed to innovative recombinant and combination vaccines. These changes have made it possible to control diseases better by increasing product safety and effectiveness.
• Increased Awareness and Education: Demand for vaccines is increasing due to improved awareness about rabies and its prevention through vaccination. Therefore, health campaigns and educational efforts are necessary for enhancing vaccination rates.
• Government Initiatives: Market expansion has been fueled by supportive government policies and funding for rabies vaccination programs. The role played by governments in scaling up immunization coverage and controlling outbreaks cannot be overemphasized.
• Expanded Access to Vaccines: Better distribution systems and logistics are making underserved areas more accessible, enabling them to receive more vaccines than before. Improved cold chain management, coupled with targeted programs, facilitates wider availability of vaccines.
• Research and Development: There is ongoing innovation in vaccine technologies, such as new delivery systems. Without this research, there would be no opportunity to develop more effective or convenient ways of vaccinating people.

Challenges in the rabies vaccine market include:

• Regulatory Hurdles: Complying with different international standards during product development or when trying to obtain approval for a vaccine can be difficult due to complex regulatory requirements. This makes navigating procedures for vaccine approval challenging and complicates product development and market entry due to the multiple standards that must be met internationally.
• High Costs: The developing and manufacturing costs associated with advanced vaccines can be very high, impacting pricing and affordability, particularly among low-resource countries where rabies is highly prevalent, such as in Africa. Producing these types of vaccines requires a significant amount of funding, creating high costs.
• Vaccine Hesitancy: Increasing vaccination rates hinges on addressing vaccine hesitancy and misinformation. Public education and engagement are required to remove barriers to vaccine acceptance.

These drivers and challenges significantly impact the rabies vaccine market by influencing innovation, access, and public health efforts. Rabies control can be improved, and vaccination coverage extended by addressing these elements.

List of Rabies Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies rabies vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the rabies vaccine companies profiled in this report include-

• Serum Institute of India
• Novartis
• Cadila Pharmaceuticals
• Merck
• Sanofi
• ADS Diagnostic
• GSK

Rabies Vaccine by Segment

The study includes a forecast for the global rabies vaccine market by product type, vaccination type, application, end use, and region.

Rabies Vaccine Market by Product Type [Analysis by Value from 2019 to 2031]:

• Baby Hamster Kidney
• Purified Chick Embryo Cell Rabies Vaccine
• Vero Cell Rabies Vaccine
• Others

Rabies Vaccine Market by Vaccination Type [Analysis by Value from 2019 to 2031]:

• Pre-Exposure Vaccination (PEV)
• Post-Exposure Prophylaxis (PEP)

Rabies Vaccine Market by Application [Analysis by Value from 2019 to 2031]:

• Animal
• Human

Rabies Vaccine Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Homecare
• Specialty Clinics
• Others

Rabies Vaccine Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Rabies Vaccine Market

The rabies vaccine market is changing rapidly due to progress in vaccine technology, increased awareness, and differing global health priorities. These trends are evident in recent developments in the United States, China, Germany, India, and Japan, which demonstrate global efforts to curb and prevent rabies.

• USA: New safety-enhanced rabies vaccines with improved post-exposure prophylaxis regimens have been developed. Recent research has led to recombinant vaccines that are more effective and have fewer side effects.
• China: Rabies vaccination programs are being expanded in China, especially in rural areas where the disease is rampant. The government has also increased funding for vaccination campaigns and studies on more potent vaccines.
• Germany: Germany's focus has shifted toward combination vaccines offering protection against many diseases, including rabies. This approach aims to create a consolidated immunization program that will increase the number of immunized individuals.
• India: New intervention programs revolve around the wider distribution of anti-rabies vaccines among vulnerable communities. Access to vaccines will be improved by conducting campaigns in public health systems and partnering with organizations involved in immunization.
• Japan: In Japan, investments in advanced research on rabies vaccinations, including novel delivery mechanisms, have been made. These innovations aim to improve the efficacy of vaccines, particularly for travelers and pet owners who prioritize convenience.

Features of the Global Rabies Vaccine Market

Market Size Estimates: Rabies vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Rabies vaccine market size by various segments, such as by product type, vaccination type, application, end use, and region in terms of ($B).

Regional Analysis: Rabies vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, vaccination types, applications, end uses, and regions for the rabies vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the rabies vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the rabies vaccine market by product type (baby hamster kidney, purified chick embryo cell rabies vaccine, vero cell rabies vaccine, and others), vaccination type (pre-exposure vaccination (PEV) and post-exposure prophylaxis (PEP)), application (animal and human), end use (hospitals, homecare, specialty clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Rabies Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Rabies Vaccine Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Rabies Vaccine Market by Product Type
  • 3.3.1: Baby Hamster Kidney
  • 3.3.2: Purified Chick Embryo Cell Rabies Vaccine
  • 3.3.3: Vero Cell Rabies Vaccine
  • 3.3.4: Others
• 3.4: Global Rabies Vaccine Market by Vaccination Type
  • 3.4.1: Pre-Exposure Vaccination (PEV)
  • 3.4.2: Post-Exposure Prophylaxis (PEP)
• 3.5: Global Rabies Vaccine Market by Application
  • 3.5.1: Animal
  • 3.5.2: Human
• 3.6: Global Rabies Vaccine Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Homecare
  • 3.6.3: Specialty Clinics
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Rabies Vaccine Market by Region
• 4.2: North American Rabies Vaccine Market
  • 4.2.1: North American Market by Product Type: Baby Hamster Kidney, Purified Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, and Others
  • 4.2.2: North American Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
• 4.3: European Rabies Vaccine Market
  • 4.3.1: European Market by Product Type: Baby Hamster Kidney, Purified Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, and Others
  • 4.3.2: European Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
• 4.4: APAC Rabies Vaccine Market
  • 4.4.1: APAC Market by Product Type: Baby Hamster Kidney, Purified Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, and Others
  • 4.4.2: APAC Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
• 4.5: ROW Rabies Vaccine Market
  • 4.5.1: ROW Market by Product Type: Baby Hamster Kidney, Purified Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, and Others
  • 4.5.2: ROW Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Rabies Vaccine Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Rabies Vaccine Market by Vaccination Type
  • 6.1.3: Growth Opportunities for the Global Rabies Vaccine Market by Application
  • 6.1.4: Growth Opportunities for the Global Rabies Vaccine Market by End Use
  • 6.1.5: Growth Opportunities for the Global Rabies Vaccine Market by Region
• 6.2: Emerging Trends in the Global Rabies Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Rabies Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Rabies Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Serum Institute of India
• 7.2: Novartis
• 7.3: Cadila Pharmaceuticals
• 7.4: Merck
• 7.5: Sanofi
• 7.6: ADS Diagnostic
• 7.7: GSK